Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy

BJOG: An International Journal of Obstetrics & Gynaecology

Volumn 102, Issue 11, 1995, Pages 861-868

 

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO;

ADULT; ARTICLE; CANADA; CHILD DEVELOPMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM;

ASPIRIN; BODY HEIGHT; BODY WEIGHT; CANADA; COHORT STUDIES; DEVELOPMENTAL DISABILITIES; DOUBLE-BLIND METHOD; FEMALE; FETAL GROWTH RETARDATION; FOLLOW-UP STUDIES; GREAT BRITAIN; HEMORRHAGE; HOSPITALIZATION; HUMANS; INFANT; PRE-ECLAMPSIA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RESPIRATION DISORDERS;

EID: 0028879998     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1995.tb10872.x     Document Type: Article

References (27)

1. The Denver developmental screening test: achievement of test norms in the first year of life
2. Learning impairment from maternal salicylate treatment in rats
3. A review of 404 late walkers
4. CLASP: a randomised trial of low‐dose aspirin for the prevention and treatment of pre‐eclampsia among 9364 pregnant women
5. Maternal and fetal effects of acetaminophen and salicylates in pregnancy
6. Antiplatelet agents for IUGR and pre‐eclampsia
7. Epidemiology of drugs taken by pregnant women: drugs that may affect the fetus adversely
8. Low dose aspirin therapy to prevent pre‐eclampsia
9. Non‐steroidal anti‐inflammatory agents
10. Mortality and morbidity of 500‐1499 g birthweight infants liveborn to residents of a defined geographic region before and after neonatal intensive care
11. Low dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy induced hypertension
12. Is late walking a marker of morbidity
13. Aspirin exposure during the first 20 weeks of gestation and IQ at four years of age
14. Analysis of records from an open audiology service
15. Outcome measures in randomised clinical trials in the very low birthweight infant
16. Follow‐up of children in the Italian Study of Aspirin in Pregnancy (letter)
17. Neonatal intracranial haemorrhage and maternal ingestion of aspirin
18. Prevention of preeclampsia with low dose aspirin in healthy nulliparous pregnant women
19. Parental developmental assessment of 18 month old children: reliability and predictive value
20. Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements
21. Clinical longitudinal standards for height, weight, height velocity, weight velocity and stages of puberty
22. Do pregnancy complications contribute to neurodevel‐opmental disability
23. Prevention of fetal growth retardation with low dose aspirin: findings of the EPREDA trial
24. Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin‐throm‐boxane balance in mother and newborn